Therefore, measurement of hepcidin concentrations in IBD might be of relevance to distinguish individuals who are likely to benefit from monoclonal antibodies versus those who will not and would require other therapeutic regimens (Loveikyte et al., 2023). This evidence concerns the gene HAMP and inflammatory bowel disease.